This analysis is brought to you by Inkwood Research, a leading market intelligence firm specialising in Asia-Pacific diagnostic imaging, hepatology technology ecosystems, and advanced ultrasound solutions. Our research team brings together deep expertise in NAFLD clinical pathways, liver disease burden across South Asian populations, and contrast agent adoption trends in Indian hospitals, tier-1 medical centres, and ambulatory diagnostic facilities. Through strategic partnerships with Indian radiologists, gastroenterology societies, and healthcare policy analysts, we deliver actionable intelligence for stakeholders navigating India's fast-evolving contrast ultrasound market. Table of Contents Why Is Liver Disease Such a Crisis in India? What Is Contrast Ultrasound and How Does It Workfor Liver Conditions? How Does CEUS Diagnose Steatosis and Focal LiverLesions? What Are the Key Barriers to Contrast Ultrasound Adoption in India? How Are Hospitals and Ambulatory Centres Integrating...